1. Home
  2. GENC vs ELTX Comparison

GENC vs ELTX Comparison

Compare GENC & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$15.94

Market Cap

222.5M

Sector

Industrials

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENC
ELTX
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.5M
185.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
GENC
ELTX
Price
$15.94
$3.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$17.60
$18.00
AVG Volume (30 Days)
28.8K
4.0M
Earning Date
02-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
8.08
39.29
EPS
0.50
N/A
Revenue
$48,943,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.51
N/A
P/E Ratio
$32.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.22
$2.66
52 Week High
$17.40
$16.00

Technical Indicators

Market Signals
Indicator
GENC
ELTX
Relative Strength Index (RSI) 66.02 36.12
Support Level $14.55 $2.72
Resistance Level $16.47 $9.76
Average True Range (ATR) 0.44 0.46
MACD 0.10 0.20
Stochastic Oscillator 57.11 13.79

Price Performance

Historical Comparison
GENC
ELTX

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: